表观遗传年龄加速与不孕症之间的关联
在挪威母亲、父亲与儿童队列研究中,比较1000对自然受孕与894对经IVF或ICSI受孕夫妇的表观遗传年龄加速。IVF母亲DunedinPoAm较非ART母亲高0.021年(P=2.89E-06),输卵管 factor、排卵 factor及不明原因不孕母亲亦升高;ICSI父亲无差异。
要点
- IVF母亲DunedinPoAm较非ART母亲高0.021年(P=2.89E-06)。
- 输卵管 factor不孕母亲DunedinPoAm升高0.030年(P=1.34E-05)。
- ICSI父亲与非ART父亲表观遗传年龄加速无差异。
核心结论
- IVF母亲与非ART母亲相比DunedinPoAm存在显著差异,但无法确定表观遗传年龄加速与不孕症之间因果方向。
研究设计与样本
- 挪威母亲、父亲与儿童队列研究于1999至2008年在挪威招募约18孕周的孕妇及其伴侣,纳入约95000名母亲、75000名父亲和114000名儿童。
- 从队列中选取1000对经性交受孕夫妇和894对经IVF(n=525)或ICSI(n=369)受孕夫妇,用Illumina MethylationEPIC阵列测DNA甲基化并计算表观遗传年龄加速。
- 采用线性混合模型比较非ART与ART父母间五种表观遗传年龄加速的差异。
主要发现
- 校正潜在混杂因素后,IVF母亲与非ART母亲DunedinPoAm差异为0.021年(P=2.89E-06)。
- 输卵管 factor不孕母亲DunedinPoAm较非ART母亲高0.030年(P=1.34E-05),排卵 factor高0.023年(P=0.0018),不明原因不孕高0.023年(P=1.39E-04)。
- 非ART与ICSI父亲间表观遗传年龄加速无差异。
- DunedinPoAm与吸烟、教育程度和产次的关联强于其他四种表观遗传年龄加速。
临床怎么用
- 原文未据此给出推荐。
局限性
- 无法确定表观遗传年龄加速与不孕症之间因果通路的方向性。
- 父母外周血样本在受孕后采集,不能排除ART母亲表观遗传谱受ART治疗影响的可能性。
- 结果应谨慎解读,且可能不能推广至非妊娠女性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY QUESTION: Is the use of ART, a proxy for infertility, associated with epigenetic age acceleration? SUMMARY ANSWER: The epigenetic age acceleration measured by Dunedin Pace of Aging methylation (DunedinPoAm) differed significantly between non-ART and ART mothers. WHAT IS KNOWN ALREADY: Among mothers who used ART, epigenetic age acceleration may be associated with low oocyte yield and poor ovarian response. However, the difference in epigenetic age acceleration between non-ART and ART mothers (or even fathers) has not been examined. STUDY DESIGN, SIZE, DURATION: The Norwegian Mother, Father and Child Cohort Study (MoBa) recruited pregnant women and their partners across Norway at around 18 gestational weeks between 1999 and 2008. Approximately 95 000 mothers, 75 000 fathers and 114 000 children were included. Peripheral blood samples were taken from mothers and fathers at ultrasound appointments or from mothers at childbirth, and umbilical cord blood samples were collected from the newborns at birth. PARTICIPANTS/MATERIALS, SETTING, METHODS: Among the MoBa participants, we selected 1000 couples who conceived by coitus and 894 couples who conceived by IVF (n = 525) or ICSI (n = 369). We measured their DNA methylation (DNAm) levels using the Illumina MethylationEPIC array and calculated epigenetic age acceleration. A linear mixed model was used to examine the differences in five different epigenetic age accelerations between non-ART and ART parents. MAIN RESULTS AND THE ROLE OF CHANCE: We found a significant difference in the epigenetic age acceleration calculated by DunedinPoAm between IVF and non-ART mothers (0.021 years, P-value = 2.89E-06) after adjustment for potential confounders. Further, we detected elevated DunedinPoAm in mothers with tubal factor infertility (0.030 years, P-value = 1.34E-05), ovulation factor (0.023 years, P-value = 0.0018) and unexplained infertility (0.023 years, P-value = 1.39E-04) compared with non-ART mothers. No differences in epigenetic age accelerations between non-ART and ICSI fathers were found. DunedinPoAm also showed stronger associations with smoking, education and parity than the other four epigenetic age accelerations. LIMITATIONS, REASONS FOR CAUTION: We were not able to determine the directionality of the causal pathway between the epigenetic age accelerations and infertility. Since parents' peripheral blood samples were collected after conception, we cannot rule out the possibility that the epigenetic profile of ART mothers was influenced by the ART treatment. Hence, the results should be interpreted with caution, and our results might not be generalizable to non-pregnant women. WIDER IMPLICATIONS OF THE FINDINGS: A plausible biological mechanism behind the reported association is that IVF mothers could be closer to menopause than non-ART mothers. The pace of decline of the ovarian reserve that eventually leads to menopause varies between females yet, in general, accelerates after the age of 30, and some studies show an increased risk of infertility in females with low ovarian reserve. STUDY FUNDING/COMPETING INTEREST(S): This study was partly funded by the Research Council of Norway (Women's fertility, project no. 320656) and through its Centres of Excellence Funding Scheme (project no. 262700). M.C.M. has received funding from the European Research Council (ERC) under the European Union's Horizon 2020 research and innovation programme (grant agreement number 947684). The authors declare no conflict of interest. TRIAL REGISTRATION NUMBER: N/A.
引用
- Lee Y, Bohlin J, Page CM, et al. Associations between epigenetic age acceleration and infertility. Hum Reprod. 2022. PMID: 35771672. doi:10.1093/humrep/deac147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。